PP31 Integrin-mediated map kinase signaling increases collagenase-3 (MMP-13) production by human articular chondrocytes  by unknown
release of cartilage matrix degrading enzyme MMP-3 (stromelysin 
1). 
Conclusions: Our findings suggest a novel mechanism by which 
synovial cells induce degradation of cartilage matrix through 
SDF-1 signaling in rheumatoid arthritis and osteoarthritis. 
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IN VlVO INTERLEUKIN-1 CONVERTING ENZYME MODULA- 
TION BY NITRIC OXIDE IN THE DOG EXPERIMENTAL 
OSTEOARTHRITIS MODEL 
C. Boileau ~, J. MarteI-Pelletier 1, F. Moldovan 1, j.y. Jouzeau 2, 
P. ~P .T .  Manning 3, J-P. Pelletier 1 
lOsteoarthritis Research Unit, CHUM: H6joita/ Notre-Dame, 
Montreal, Qu6bec, H2L 4M1, Canada; z Universit~ Henri 
Poincare, Vandoeuvre-Les-Nancy, 54505, France; 3 Pharmacia 
Corp., St. Louis, MO, 63198, USA 
Aim: The aim of this study was to investigate the relationship 
between two key mediators implicated in cartilage osteoarthritis 
(OA): nitric oxide (NO) and interleukin (IL)-I converting enzyme 
(ICE). IL- 18 was also studied and served as reference to the 
effect of ICE. 
Method: For this study, an OA model was created by sectioning 
the anterior cruciate ligament (ACL) of the right stifle joint of dogs 
by a stab wound. Dogs were separated into experimental groups: 
I) unoperated ogs that received no treatment; II) operated dogs 
(OA) that received no treatment, and III) operated dogs (OA) that 
received oral N-iminoethyt-L-lysine (L-NIL, a specific iNOS 
inhibitor; 10 mg/kg/day) starting immediately after surgery. The 
OA clogs were killed 12 weeks after surgery. In a second set of 
experiments, ACL was induced in dogs for 12 weeks, and femoral 
condyles dissected and incubated with specific inhibitors of 
important signaling pathways involved in the OA process, name- 
ly SB 202190 (10 raM, p38 MAP kinase inhibitor), PD 98059 (100 
mM, MEK 1/2 inhibitor), NS-398 (10 mM, specific cyclooxyge- 
nase-2 inhibitor), SN-50 (50 raM, NF-kB inhibitor) and L-NIL (50 
mM). Specimens were processed for in situ hybridization or 
immunohistochemistry for ICE and IL-18, followed by a morpho- 
metric analysis. 
Results: Data showed that ICE and IL-18 were both present in 
vivo in dog cartilage. Compared to normal, their levels were sig- 
nificantly increased in the OA dog cartilage. L-NIL treatment 
induced a decrease (p<0.001) of ICE and IL-18 levels throughout 
the OA tissue for both the femoral condyles and tibial plateaus; 
values were similar to normal dogs. This effect, however, 
appeared to occur post-transcriptionally as L-NIL did not affect 
ICE mRNA levels as demonstrated by in situ hybridation. 
Interestingly, in vitro experiments demonstrated a significant inhi- 
bition of the ICE levels by the above inhibitors except L-NIL, indi- 
cating that in vivo the NO effect is not direct but requires inter- 
mediaries. 
Conclusion: In this study, we demonstrated the in vivo effective- 
ness of a specific NO inhibitor in completely reversing the OA 
enhanced ICE and IL-18 synthesis levels. Data further suggests 
that the in vivo NO inhibition of ICE levels requires intermediary 
factors. 
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GENE TRANSFER INTO THE PERIOSTEAL GRAFTS FOR 
ARTICULAR CARTILAGE DEFECTS USING GENE GUN 
SYSTEM 
T. Yamashita, Y. Wada, K. Nakagawa, K. Takase, K. Tsuchiya, 
H. Moriya 
Department of Orthopaedic Surgery, Chiba University, Chiba, 
Japan 
Aim: The aim of this study was to examine expression rate and 
duration of LacZ marker gene transfected by gene gun and to 
analyze tissue damage of the periosteal grafts. 
Methods: Twelve adult male New Zealand White rabbits weigh- 
ing average 3.20kg were used. Periosteal grafts were harvested 
from the medial proximal tibia and LacZ marker gene (pCMV b) 
was transferred into cambium layer of the grafts by gene gun. The 
grafts was placed on the articular cartilage defects on the femoral 
component of patellofemoral joint with the cambium layer facing 
down on the articular surface. LacZ gene transfer was not per- 
formed in the control grafts. The animals were sacrificed at 2,4 
and 12 weeks after operation and the knee joints were harvested 
for gross macroscopical observation, followed by histopatholog- 
ical examination. The newly formed tissue was assessed by the 
semiquantitative histological grading system (0-14 points), and 
the efficiency of gene transfer was calculated by counting the 
number of total cells and LacZ positive cells in the central area. 
Results: The total histological score of repair tissue at 2 weeks 
was 11.3 +1.3 (mean+SD) points in the LacZ group and 11.5 
points in the control group. At 4 weeks, it was 5.6±1.1 in the LacZ 
group and 5.3± 1.2 in the control (low score indicating better car- 
tilage repair). These results indicates that the gene gun does not 
affect the tissue repair process of periosteal grafting. 
The average LacZ positive rate was 13.0% at 2 weeks and 8.9% 
at 4 weeks. 
Conclusions: The expression of LacZ was observed at 4 weeks 
after grafting with neither inflammation or tissue damage. The in 
situ gene delivery system using ene gun seems to be suitable for 
gene therapy in the Orthopaedic field since it has less risk of sys- 
tematic effects than in vivo methods with viral vectors, it is easi- 
er to perform than ex vivo methods, and it can provide local 
transfection during surgery 
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INTEGRIN-MEDIATED MAP KINASE SIGNALING INCREASES 
COLLAGENASE-3 (MMP-13) PRODUCTION BY HUMAN 
ARTICULAR CHONDROCYTES 
Christopher B. Forsyth, Richard F. Loeser 
Departments of Medicine and Biochemistry Rush Medical 
College, Chicago,/L, USA 
Aim: The aim of this study was to determine if integrin-mediated 
signaling results in activation of chondrocyte mitogen-activated 
protein (MAP) kinases which lead to increased expression of 
MMP-13 (collagenase 3), a potent mediator of cartilage matrix 
degradation. 
Methods: Human articular chondrocytes in primary confluent 
monolayer cultures were treated with integrin blocking antibodies 
and fibronectin fragments. MAP kinases were analyzed by 
immunobtotting with phospho-specific antibodies and MMP-13 
production was measured in conditioned media by immunoblot- 
ting and with a peptide substrate based assay. 
Results: Chondrocytes were found to respond to the 120 kDa 
fibronectin fragment and to blocking antibodies to the 0~?.1~1 and 
c(5131 integrins with increased phosphorylation of the ERK1, 
ERK2, JNK, and p38 MAP kinases. Intact fibronectin and block- 
S12 
ing antibodies to c(1, (~3, and (xVI33 integrins as well as a non- 
blocking (z5131 antibody had no affect. MAP kinase activation 
was associated with increased phosphorylation of pyk2 but not 
focal adhesion kinase. Subsequent to MAP kinase activation 
increased phosphorylation of c-Jun and the NFkB inhibitor lkB 
was noted, followed by increased pro- and activated MMP-13 in 
the conditioned media. Inhibitors of MEK and p38 were both able 
to inhibit he increased MMP-13 production while the interleukin 
1 receptor antagonist protein did not. However, the IL-1 receptor 
antagonist partially inhibited fibronectin fragment induced activa- 
tion of MMP-13. 
Conclusion: These results suggest that disruption of chondro- 
cyte binding to a native matrix by a5bl blocking antibodies or 
fibronectin fragments stimulates integrin-mediated MAP kinase 
activation resulting in increased production and release of pro- 
and active MMP-13. Autocrine production of It_-I results in addi- 
"tional MMP-13 activation. 
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ONCOSTATIN M INDUCES COLLAGEN DEGRADATION IN 
HUMAN ARTICULAR CARTILAGE 
LM Atlev. K Carlson, TA Pietka, DR Eyre 
Department of Orthopaedic and Sports Medicine, University of 
Washington, Seattle, WA, USA 
Aim: This study investigated the effect of oncostatin-M (OSM) on 
collagen degradation in explants of human articular cartilage. 
Methods: Monoclonat antibody (mAb) 2B4 was raised against a 
sequence from the C-telopeptide cross-linking domain of type 11 
collagen and recognizes a neoepitope of matrix metallopro- 
teinase cleavage. Full thickness plugs of human articular cartilage 
from the tibial plateau (banked tissue) or femoral condyle (surgi- 
cal amputation) were cultured in DMEM at 37°C in the presence 
or absence of recombinant human OSM (50 ng/ml) for up to 4 
weeks. Conditioned media were collected every 7 days and 
assayed for collagen fragments by competition ELISA based on 
mAb 2B4. Cartilage plugs were recovered after 1, 3 or 7 days of 
culture for immunohistochemical analysis using mAb 2B4. 
Results: Assay of the culture media showed elevated levels of 
2B4 epitope in OSM-treated cartilage plugs after 14 days of cul- 
ture (OSM-treated 29.8 ± 5.3 ng/ml vs control 15.5 ± 3.4 ng/ml, P 
= 0.006). By day 28, medium 2B4 epitope levels reached 208,0 
± 102.0 ng/ml for OSM-treated plugs compared with 39.0 _+.+ 7.0 
ng/ml for control plugs (P = 0.045). Cartilage plugs analyzed for 
2B4 epitope by immunohistochemistry showed strong pericellu- 
lar staining in plugs treated with OSM for 3 to 7 days. The 2B4 
signal was virtually absent from control plugs cultured without 
OSM, and from plugs cultured with OSM for tess than 3 days. 
Conclusion: OSM, a proinflammatory c tokine found in high lev- 
els in human rheumatoid synovial fluids, induces collagen degra- 
dation in human articular cartilage in vitro. Degraded collagen 
fragments are seen in the tissue after 3 to 7 days of OSM-treat- 
ment, sooner than reports of collagenase upregulation following 
cytokine stimulation. The findings support a concept that 
telopeptidase activity initiates collagen fibril degradation in this 
system. 
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ATP INDUCED-PROSTAGLANDIN E2 SYNTHESIS IS MEDI- 
ATED BY ERKI/2 AND P38 MAP KINASES VIA P2Y RECEP- 
TORS IN ARTICULAR CHONDROCYTES 
S. Thidon 1,L Humbert ~, G Bereziat 1, F Berenbaum ~ 2 
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Aim: The aim of this study was to assess the effects of ATP on 
the secretory profiles of prostanoids and the coupled signaling 
and enzymatic events in primary cultured monolayers of rabbit 
articular chondrocytes. ATP is an inflammatory mediator that is 
released from immune cell activation and damaged tissue at sites 
of inflammation. 
Results: ATP increased PGE2 release in a dose dependent fash- 
ion, with an activation threshold at 10 mM ATP and a 4.7-fold 
increase in PGE2 output at 100 mM ATP. ATP-induced PGE2 was 
detectable as soon as 2 rain, and reached maximum level at 1 
hour. Purinoceptor agonists stimulated PGE2 release by the 
chondrocytes with the following rank order of potency ATP = UTP 
ATPgS > ADR Adenosine was ineffective. The P2 receptor selec- 
tive antagonists suramin and reactive blue-2 inhibited ATP- 
induced PGE2 release. These results strongly suggest that ATP 
causes the release of PGE2 via the stimulation of P2Y receptors. 
Furthermore, extracellular nucleotides stimulated a rapid, tran- 
sient and concentration-dependent activation of stress- and 
mitogen activated protein kinases (SAPK and MAPK), respective- 
ly p38 and ERKI/2, as measured by phosphorylation of the both 
kinases. The activation of p38 kinase and ERKI/2 by ATP and UTP 
was dose dependently attenuated by suramin. 
To understand the enzymatic cascade implicated in the ATP 
dependent PGE2 release, we first tested AACOCF3, an inhibitor 
of cPLA2 and BEL, an inhibitor of the iPLA2. The response 
induced by ATP was not affected by BEL and completely blocked 
by AACOCF3, suggesting that cPLA2 mediated the release of 
PGE2 in response to purinergic agonists. A complete blockade of 
the ATP-induced PGE2 release was observed with each inhibitor 
of the MAPKinases PD 98059 and 5B203580. In contrast, the 
release of arachidonic acid in response to ATP was only affected 
by PD 98059, suggesting that cPLA2 activation was mediated 
through activation of the ERKI/2 MAPKinase. The following enzy- 
matic events were investigated with the use of NS-398, a selec- 
tive COX-2 and PGE-synthase inhibitor and SC-560, a selective 
COX-1 inhibitor. Both of them prevented ATP-induced PGE2 
release. 
Conclusion: We conclude that extracellular ATP, acting via P2Y- 
purinoceptors, stimulates PGE2 release from articular chondro- 
cytes and thus may have physiological and pathological effects 
in articular cartilage. 
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SEQUENTIAL CLEAVAGE OF AGGRECAN IN BOVINE ARTIC- 
ULAR CARTILAGE BY HUMAN RECOMBINANT AGGRE- 
CANASE MIMICS INTERLEUKIN-1 INDUCED CARTILAGE 
TURNOVER 
SM Hwang, SM Blake, AM Badger, T Ho, RB Kirkpatrick, 
T Newman-Tarr, BA Swift, B Bradley, IE James, S Kumar, 
M Gowen, MW Lark. 
Department of Musculoskeletal Diseases, GSK Pharmaceuticals, 
King of Prussia, PA, USA 
Aim: The aim of this study was to track the process of aggre- 
canolysis in intact bovine articular cartilage (BAC) induced by 
recombinant human interleukin-lb (IL-1) or by the action of 
recombinant human aggrecanase-1 (rhAgg-1) in vitro using 
immunocytocheimcal methods. 
